Omega-3 Supplementation in the Prevention of Contrast Induced Nephropathy in Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial
Purpose: Contrast-induced nephropathy (CIN) is the third cause of hospital-acquired renal failure and is associated with significant morbidity and mortality. Several studies have revealed the protective role of omega-3 in prevention and treatment of some kidney injuries. This study was conducted to...
Main Authors: | Farzaneh Foroughinia, Mahtabalsadat Mirjalili, Ehsan Mirzaei, Alireza Oboodi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2019-06-01
|
Series: | Advanced Pharmaceutical Bulletin |
Subjects: | |
Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-23092 |
Similar Items
-
Impact of supplementation with omega-3 in the prevention of contrast-induced nephropathy following elective percutaneous coronary intervention in patients with chronic kidney disease: A randomized placebo-controlled trial
by: Farzaneh Foroughinia, et al.
Published: (2020-01-01) -
Diagnostic accuracy of serum cystatin C for early recognition of contrast induced nephropathy in Western Indians undergoing cardiac catheterization
by: Anand N. Shukla, et al.
Published: (2017-05-01) -
Significance of cystatin C for early diagnosis of contrast-induced nephropathy in Iraqi patients undergoing coronary angiography
by: Zahraa Malik Abood, et al.
Published: (2021-01-01) -
Effect of pretreatment with omega-3 supplement on cardiac necrosis markers in chronic kidney disease patients undergoing elective percutaneous coronary intervention
by: Farzaneh Foroughinia, et al.
Published: (2017-01-01) -
Diagnostic Value of Cystatin C and Creatinine Detection in Blood Serum of Newborns at Ischemic Nephropathy
by: A.M. Loboda, et al.
Published: (2012-02-01)